| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 11 |
| 1 | TRIAMCINOLONE ACETONIDE | 7 |
| 2 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 7 |
| 3 | PREDNISOLONE | 5 |
| 4 | PREDNISOLONE ORAL | 5 |
| 5 | PREDNISOLONE ORAL SOLUTION | 5 |
| 6 | BEVACIZUMAB | 3 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 8 | ATORVASTATIN CALCIUM | 2 |
| 9 | DEXAMETHASONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 1 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 2 | MARAVIROC | 2 | 0.0009 |
| 3 | PENICILLIN G | 1 | 0.0004 |
| 4 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 7 | 0.0003 |
| 5 | FOSCARNET SODIUM | 1 | 0.0002 |
| 6 | ETRAVIRINE | 1 | 0.0002 |
| 7 | NEVIRAPINE | 2 | 0.0002 |
| 8 | TRIAMCINOLONE ACETONIDE | 7 | 0.0002 |
| 9 | ZIDOVUDINE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 9 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |